The global industry size was valued at $7.1 billion in 2023, and is projected to reach $11.6 billion by 2033, registering a CAGR of 5.1% from 2024 to 2033. 

The sector is projected to exhibit growth at a compound annual growth rate of 6.5% from 2021 to 2030. It was valued at $6.6 billion in 2020 and is anticipated to reach $12.3 billion by 2030.  

The global industry is expected to reach $618.71 million by 2030. The body composition analyzers market was valued at $398.22 million in 2020 and is projected to experience a compound annual growth rate of 4.5% from 2021 to 2030.

The global narcolepsy drugs market was $2,680.06 million in 2020 and is projected to reach $6,667.80 million by 2030, registering a CAGR of 9.6% from 2021 to 2030.   

The global industry was valued at $13.8 billion in 2024, and is projected to reach $23.1 billion by 2034, growing at a CAGR of 5.3% from 2025 to 2034.

According to the report, the pharmacovigilance sector was valued at $8.2 billion in 2024. It is projected to reach $26.2 billion by 2034, growing at a CAGR of 12.3% from 2025 to 2034.  

The global aortic endografts market was valued at $3.3 billion in 2024, and is projected to reach $6.2 billion by 2034, growing at a CAGR of 6.3% from 2025 to 2034. 

The pet DNA testing market is projected to grow at a CAGR of 9.3% from 2025 to 2034.

According to the report, the exosome diagnostic and therapeutic sector was valued at $0.2 billion in 2020. It is projected to reach $2.9 billion by 2030, growing at a CAGR of 29.4% from 2021 to 2030. 

As per the report published by Allied Market Research on laboratory balances and scales market, the sector is projected to grow at a CAGR of 4.4% from 2022 to 2031.